308 related articles for article (PubMed ID: 28283175)
1. Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children.
Li X; Zhang Y; Liu H; Jiang H; Ge H; Zhang Y
Am J Cardiol; 2017 May; 119(9):1366-1370. PubMed ID: 28283175
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with propafenone for cardiac arrhythmias in the young.
Heusch A; Kramer HH; Krogmann ON; Rammos S; Bourgeous M
Eur Heart J; 1994 Aug; 15(8):1050-6. PubMed ID: 7527342
[TBL] [Abstract][Full Text] [Related]
3. Sotalol for atrial tachycardias after surgery for congenital heart disease.
Beaufort-Krol GC; Bink-Boelkens MT
Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2125-9. PubMed ID: 9272523
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Pharmacological Therapy of Ectopic Atrial Tachycardia in Children.
Ge H; Li X; Liu H; Jiang H
Pediatr Cardiol; 2017 Feb; 38(2):289-295. PubMed ID: 27882422
[TBL] [Abstract][Full Text] [Related]
5. Arrhythmias in the intensive care patient.
Trappe HJ; Brandts B; Weismueller P
Curr Opin Crit Care; 2003 Oct; 9(5):345-55. PubMed ID: 14508146
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.
Bellandi F; Simonetti I; Leoncini M; Frascarelli F; Giovannini T; Maioli M; Dabizzi RP
Am J Cardiol; 2001 Sep; 88(6):640-5. PubMed ID: 11564387
[TBL] [Abstract][Full Text] [Related]
7. Atrial tachycardias in young adults and adolescents with congenital heart disease: conversion using single dose oral sotalol.
Rao SO; Boramanand NK; Burton DA; Perry JC
Int J Cardiol; 2009 Aug; 136(3):253-7. PubMed ID: 18653253
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
Luedtke SA; Kuhn RJ; McCaffrey FM
Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
[TBL] [Abstract][Full Text] [Related]
9. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group.
Vos MA; Golitsyn SR; Stangl K; Ruda MY; Van Wijk LV; Harry JD; Perry KT; Touboul P; Steinbeck G; Wellens HJ
Heart; 1998 Jun; 79(6):568-75. PubMed ID: 10078083
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias.
Sahar DI; Reiffel JA; Bigger JT; Squatrito A; Kidwell GA
Am Heart J; 1989 Mar; 117(3):562-8. PubMed ID: 2919535
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of ibutilide for termination of atrial fibrillation and flutter.
Ellenbogen KA; Clemo HF; Stambler BS; Wood MA; VanderLugt JT
Am J Cardiol; 1996 Oct; 78(8A):42-5. PubMed ID: 8903275
[TBL] [Abstract][Full Text] [Related]
12. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter].
Cruz Cruz F; Iturralde Torres P; Picos Bovio E; Medeiros Domingo A; Infante Vázquez O
Arch Inst Cardiol Mex; 1998; 68(6):482-91. PubMed ID: 10365224
[TBL] [Abstract][Full Text] [Related]
13. [Tachycardias: considerations in childhood in the 90s].
Gutiérrez-Larraya F; Jabón A
An Esp Pediatr; 1993 Dec; 39(6):475-88. PubMed ID: 8166400
[No Abstract] [Full Text] [Related]
14. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.
van der Heijden LB; Oudijk MA; Manten GT; ter Heide H; Pistorius L; Freund MW
Ultrasound Obstet Gynecol; 2013 Sep; 42(3):285-93. PubMed ID: 23303470
[TBL] [Abstract][Full Text] [Related]
15. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of D,L-sotalol in post-ablative atrial arrhythmias in patients with atrial fibrillation treated with radiofrequency ablation].
Mihálcz A; Földesi C; Kardos A; Ladunga K; Szili-Török T
Orv Hetil; 2009 Sep; 150(36):1694-700. PubMed ID: 19709984
[TBL] [Abstract][Full Text] [Related]
17. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
[TBL] [Abstract][Full Text] [Related]
18. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group.
Sung RJ; Tan HL; Karagounis L; Hanyok JJ; Falk R; Platia E; Das G; Hardy SA
Am Heart J; 1995 Apr; 129(4):739-48. PubMed ID: 7900626
[TBL] [Abstract][Full Text] [Related]
19. [Results of oral sotalol therapy in children with supraventricular and ventricular arrhythmias].
Paul T; Lehmann C; Pfammatter JP; Kallfelz HC
Z Kardiol; 1994 Dec; 83(12):891-7. PubMed ID: 7531374
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
Fragakis N; Papadopoulos N; Papanastasiou S; Kozirakis M; Maligkos G; Tsaritsaniotis E; Katsaris G
Pacing Clin Electrophysiol; 2005 Sep; 28(9):954-61. PubMed ID: 16176535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
